214 related articles for article (PubMed ID: 25234407)
1. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.
Lötsch F; Königsbrügge O; Posch F; Zielinski C; Pabinger I; Ay C
Thromb Res; 2014 Nov; 134(5):1008-13. PubMed ID: 25234407
[TBL] [Abstract][Full Text] [Related]
2. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
[TBL] [Abstract][Full Text] [Related]
3. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
Pai M; Evans NS; Shah SJ; Green D; Cook D; Crowther MA
Thromb Res; 2011 Nov; 128(5):422-30. PubMed ID: 21641019
[TBL] [Abstract][Full Text] [Related]
4. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
5. Lipid lowering drugs and the risk of recurrent venous thromboembolism.
Delluc A; Tromeur C; Le Moigne E; Nowak E; Mottier D; Le Gal G; Lacut K
Thromb Res; 2012 Dec; 130(6):859-63. PubMed ID: 22939687
[TBL] [Abstract][Full Text] [Related]
6. Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism.
Resh M; Mahmoodi BK; Navis GJ; Veeger NJ; Lijfering WM
Thromb Res; 2011 May; 127(5):395-9. PubMed ID: 21277007
[TBL] [Abstract][Full Text] [Related]
7. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
[TBL] [Abstract][Full Text] [Related]
8. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
[TBL] [Abstract][Full Text] [Related]
9. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
10. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
11. Statins decrease the occurrence of venous thromboembolism in patients with cancer.
Khemasuwan D; Divietro ML; Tangdhanakanond K; Pomerantz SC; Eiger G
Am J Med; 2010 Jan; 123(1):60-5. PubMed ID: 20102993
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia, statins, and venous thromboembolism.
Poredos P; Jezovnik MK
Semin Thromb Hemost; 2011 Nov; 37(8):897-902. PubMed ID: 22198854
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
[TBL] [Abstract][Full Text] [Related]
14. Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisation.
Rabinowich L; Steinvil A; Leshem-Rubinow E; Berliner S; Zeltser D; Rogowski O; Shalev V; Raz R; Chodick G
Heart; 2012 Dec; 98(24):1817-21. PubMed ID: 23038788
[TBL] [Abstract][Full Text] [Related]
15. [Statins can maybe reduce the risk of venous thromboembolism].
Toft-Petersen AP; Thomsen RW; Schmidt EB; Larsen TB
Ugeskr Laeger; 2011 May; 173(22):1558-63. PubMed ID: 21627898
[TBL] [Abstract][Full Text] [Related]
16. Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry).
Yoshikawa Y; Yamashita Y; Morimoto T; Mabuchi H; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Murakami T; Kimura T;
Am J Cardiol; 2020 Jan; 125(2):189-197. PubMed ID: 31744599
[TBL] [Abstract][Full Text] [Related]
17. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.
Tagalakis V; Eberg M; Kahn S; Azoulay L
Thromb Haemost; 2016 Jun; 115(6):1220-8. PubMed ID: 26819144
[TBL] [Abstract][Full Text] [Related]
18. Statin use and the prevention of venous thromboembolism: a meta-analysis.
Agarwal V; Phung OJ; Tongbram V; Bhardwaj A; Coleman CI
Int J Clin Pract; 2010 Sep; 64(10):1375-83. PubMed ID: 20716146
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
20. Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study.
El-Refai SM; Black EP; Adams VR; Talbert JC; Brown JD
Thromb Res; 2017 Oct; 158():49-58. PubMed ID: 28822240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
